Skip to main content
. 2020 Sep 2;7:123. doi: 10.3389/fnut.2020.00123

Table 1.

Results of the Mendelian Randomization (MR) analysis for 10-heptadecenoate (17:1) and cardiovascular events.

Exposures MR Heterogeneity Pleiotropy
Method beta SE p Method Q p Intercept SE p
Coronary heart disease MR Egger 0.8635 1.306 0.5447 MR-Egger 2.963 0.558 −0.023 0.025 0.415
WM −0.2906 0.2939 0.3228
IVW −0.3047 0.23 0.1852 IVW 3.863 0.576
RAPS −0.298 0.245 0.2239
Myocardial infarction MR Egger 2.281 1.457 0.1925 MR-Egger 2.003 0.736 −0.054 0.028 0.124
WM −0.2342 0.3345 0.4838
IVW −0.505 0.2754 0.06677 IVW 5.774 0.362
RAPS −0.544 0.304 0.07355
Cardioembolic stroke MR Egger −2.272 4.623 0.6488 MR-Egger 3.426 0.485 0.043 0.088 0.652
WM −0.4173 1.073 0.6973
IVW −0.05633 0.8168 0.945 IVW 3.725 0.596
RAPS −0.1773 0.8609 0.8368
Ischemic stroke MR Egger 1.04 2.317 0.6769 MR-Egger 1.266 0.865 −0.022 0.044 0.638
WM −0.09585 0.5161 0.8527
IVW −0.121 0.4098 0.7679 IVW 1.595 0.911
RAPS −0.1232 0.4288 0.7738

WM, Weighted median; IVW, Inverse variance weighted; SE, standard error; beta, beta-coefficients; MR, Mendelian randomization; RAPS, Robust Adjusted Profile Score.